COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 237: Articles 2361-2370  | Next

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of phase 2 antiviral studies
Wongnak, P., Schilling, W. H. K., Jittamala, P., Boyd, S. H. K., Luvira, V., Siripoon, T., Ngamprasertchai, T., Batty, E. M., Singh, S., Kouhathong, J., Pagornrat, W., Khanthagan, P., Hanboonkunupakarn, B., Poovorawan, K., Mayxay, M., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Ashley, E. A., Dondorp, A. M., Day, N. P., Teixeira, M. M., Piyaphanee, W., Phumratanaprapin, W., White, N. J., Watson, J. A., PLATCOV Collaborative Group
10.1101/2024.01.16.24301342 — Posted: 2024-01-17
Pre-event psychiatric states predict trajectories of post-traumatic stress symptoms during the COVID-19 pandemic
Nakai, F., Kubo, T., Oka, T., Kobayashi, N., Tanichi, M., Murakami, M., Hamamura, T., Honjo, M., Miyake, Y., Ide, K., Cortese, A., Nagamine, M., Chiba, T.
10.1101/2024.01.14.23300571 — Posted: 2024-01-16
Heterogeneity in deaths of despair: excess mortality in the US during the Covid-19 pandemic
Kandula, S., Keyes, K. M., Shaman, J.
10.1101/2024.01.14.24301291 — Posted: 2024-01-16
Social inequalities in COVID-19 deaths by area-level income: patterns over time and the mediating role of vaccination in a population of 11.2 million people in Ontario, Canada
Wang, L., Swayze, S., Bodner, K., Calzavara, A., Harrigan, S. P., Siddiqi, A., Baral, S. D., Austin, P. C., Smylie, J., Koh, M., Sbihi, H., Sander, B., Kwong, J. C., Mishra, S.
10.1101/2024.01.15.24301331 — Posted: 2024-01-16
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody
Johnson, N. V., Wall, S., Kramer, K., Holt, C., Periasamy, S., Richardson, S., Suryadevara, N., Andreano, E., Paciello, I., Pierleoni, G., Piccini, G., Huang, Y., Ge, P., Allen, J., Uno, N., Shiakolas, A., Pilewski, K., Nargi, R., Abu-Shmais, A., Sutton, R., Parks, R., Haynes, B., Carnahan, R., Crowe, J., Montomoli, E., Rappuoli, R., Bukreyev, A., Ross, T., Sautto, G., Georgiev, I., McLellan, J.
10.1101/2024.01.15.575741 — Posted: 2024-01-16
Adsorption-driven deformation and landing-footprints of the RBD proteins in SARS-CoV-2 variants onto biological and inanimate surfaces
Bosch, A., V. Guzman, H., Perez, R.
10.1101/2024.01.15.575706 — Posted: 2024-01-16
AnnoView enables large-scale analysis, comparison, and visualization of microbial gene neighborhoods
Wei, X., Tan, H., Lobb, B., Zhen, W., Wu, Z., Parks, D. H., Neufeld, J. D., Moreno-Hagelsieb, G., Doxey, A. C.
10.1101/2024.01.15.575735 — Posted: 2024-01-16
mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions
Bakos, T., Meszaros, T., Kozma, G. T., Berenyi, P., Facsko, R., Farkas, H., Dezsi, L., Heirman, C., de Koker, S., Schiffelers, R., Glatter, K. A., Radovits, T., Szenasi, G., Szebeni, J.
10.1101/2024.01.12.575122 — Posted: 2024-01-15
Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2
Xu, L., Yu, D., Xu, M., Yang, L.-X., Zou, Q.-C., Feng, X.-L., Li, M.-H., Sheng, N., Yao, Y.-G.
10.1101/2024.01.13.575537 — Posted: 2024-01-15
Kidney Replacement Therapy in COVID-19-Related Acute Kidney Injury: the Importance of Timing
Almeida, C. A., Oliveira, M. F., Teixeira, A. M., Cabrera, C. P., Smolentzov, I., Reichert, B. V., Lins, P. R., Rodrigues, C. E., Seabra, V. F., Andrade, L. C.
10.1101/2024.01.13.24301272 — Posted: 2024-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).